Seoul Pharma Co Ltd banner
S

Seoul Pharma Co Ltd
KOSDAQ:018680

Watchlist Manager
Seoul Pharma Co Ltd
KOSDAQ:018680
Watchlist
Price: 1 970 KRW -0.71% Market Closed
Market Cap: ₩23B

Intrinsic Value

The intrinsic value for Seoul Pharma Co Ltd (018680) under the Base Case is 2 077.19 KRW. Compared with the current market price of 1 970 KRW, the stock appears Undervalued by 5% .

Intrinsic value calculated using DCF
₩2 077.19
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
2 077.19
Undervaluation 5%
Intrinsic Value
Price ₩1 970
S
Monitor Seoul Pharma Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩1 661.75
Get notified when the price drops into your buy zone
Intrinsic Value ₩2 077.19
Current Price ₩1 970
Margin of Safety 20% ₩1 661.75
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Seoul Pharma Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Seoul Pharma Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Seoul Pharma Co Ltd.

Explain Valuation
Alternatives to Seoul Pharma Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Seoul Pharma Co Ltd stock?

The intrinsic value for Seoul Pharma Co Ltd (018680) under the Base Case is 2 077.19 KRW.

Is Seoul Pharma Co Ltd stock undervalued or overvalued?

Compared with the current market price of 1 970 KRW, the stock appears Undervalued by 5% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett